Navidea生物制药(NAVB)

LAES1682021-02-23 01:34

$Navidea生物制药(NAVB)$ 上车查看全文

LAES1682021-02-05 00:41

$Navidea生物制药(NAVB)$ 上车了查看全文

兔斯基不吃面2020-05-22 20:26

$Navidea生物制药(NAVB)$ 下一个轮到ABUS生物制药哈哈哈，异曲同工查看全文

南無哈利路亚2020-05-22 18:12

$Navidea生物制药(NAVB)$ 今天看你查看全文

荣耀之战2020-05-22 06:41

$Navidea生物制药(NAVB)$ 盘后什么消息了？查看全文

小水大雨2019-12-31 01:40

$Navidea生物制药(NAVB)$ 未来几天， 估计持续上涨的机率比较大。 但是交易量很低的小盘股， 知适合很小的资金投机一下。 买了200股， 试试运气查看全文

用户48783635432019-04-09 14:29

【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验，此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈，宣布重启对NAV3-31的2b期临床试验计划，评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文

鹰眼20072019-04-08 19:54

$Navidea生物制药(NAVB)$ wow查看全文

鹰眼20072019-03-24 13:10

$Navidea生物制药(NAVB)$ 查看全文

艾萨克的猫2018-10-23 23:00

$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-26 AccNo: 0001437749-19-008036 Size: 31 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Stateme...

$Navidea生物制药(NAVB)$ 美东时间 2019-04-26 拆合股: 20合1 网页链接

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-19 AccNo: 0001437749-19-007613 Size: 42 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.03: Material Modifications to Rights of Security HoldersI...

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-04-08 AccNo: 0001437749-19-006744 Size: 48 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 9.01: Financial Statements and Exhibits 网页链接

$Navidea生物制药(NAVB)$ 内部交易: 2019-03-22,10% Owner,Scott John K Jr. ,买入,357143普通股, $0.14

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-03-25 AccNo: 0001437749-19-005549 Size: 40 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Navidea生物制药(NAVB)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-15 AccNo: 0001437749-19-005086 Size: 11 MB 网页链接

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-03-07 AccNo: 0001437749-19-004334 Size: 191 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-02-21 AccNo: 0001437749-19-003001 Size: 23 KBItem 8.01: Other Events 网页链接

$Navidea生物制药(NAVB)$ 8-K - Current report Filed: 2019-02-01 AccNo: 0001437749-19-001640 Size: 33 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 9.01: Financial Statements and Exhibits 网页链接